KURA — Kura Oncology, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1422143 ·
Last close
$10.52
Market Cap
$935.87M
52W High
$13.90
52W Low
$7.36
ADV30
1,794,710
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 20,874,000 | 20,631,000 | -73,010,000 | -68,327,000 | 587,791,000 | 70,242,000 | 539,360,000 |
| Mar 2026 | 18,265,000 | 18,003,000 | -78,815,000 | -73,333,000 | 652,551,000 | 39,083,000 | 544,668,000 |
| Dec 2025 | 17,336,000 | — | -86,268,000 | -80,999,000 | 738,363,000 | 149,099,000 | 564,228,000 |
| Sep 2025 | 20,750,000 | — | -79,997,000 | -74,116,000 | 649,381,000 | 95,287,000 | 406,839,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-77,985,000
Investing CF
$64,080,000
Financing CF
$1,719,000
CapEx
$-6,474,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.35
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,247,421,000
Inventory
$843,000
Receivables
$9,348,000
ST Investments
$541,740,000
EBIT TTM
$-293,025,000
Pretax Income TTM
$-294,491,000
Interest Exp TTM
$1,466,000
Analysts
12
Yahoo Snapshot (yfinance, live)
Total Revenue
$77,225,000
EBITDA
$-316,799,008
Free Cash Flow
$-165,880,752
Enterprise Value
$518,691,456
Total Cash
$519,024,992
Total Debt
$24,455,000
Shares Out
88,960,619
Trailing EPS
$-3.37
Book Value
$0.54
ROE
-167.7%
ROA
-31.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 67,482,000 | -303,631,000 | -278,666,000 | 738,363,000 | 564,228,000 | 174,135,000 | -64,058,000 |
| Dec 2024 | 53,883,000 | -193,195,000 | -173,983,000 | 760,159,000 | 346,519,000 | 413,640,000 | 134,317,000 |
| Dec 2023 | 0 | -165,804,000 | -152,631,000 | 448,935,000 | 51,662,000 | 397,273,000 | -124,824,000 |
| Dec 2022 | 0 | -139,865,000 | -135,840,000 | 456,306,000 | 36,028,000 | 420,278,000 | -110,062,000 |
TTM Snapshot
Revenues TTM
$71,639,000
NetIncome TTM
$-294,570,000
OpCashFlow TTM
—
Assets (Latest)
$652,551,000
Forward EPS
$-2.30
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $13.00 · spot: $10.52 · call volume: 438 · put volume: 1,100
Expected Move to 2026-10-16:
±$1.04
(9.89%) —
implied range
$9.48 –
$11.56
· ATM straddle on $11.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ANRO | Alto Neuroscience, Inc. | $942.99M | $24.03 | — |
| AKTS | Aktis Oncology, Inc. | $953.47M | $17.74 | — |
| SPTX | Seaport Therapeutics, Inc. | $958.73M | $17.91 | — |
| ANL | Adlai Nortye Group Ltd. | $910.97M | $15.51 | — |
| RIGL | RIGEL PHARMACEUTICALS INC | $910.08M | $48.72 | — |
News headlines (Yahoo Finance, 1h cache)
Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian’s Launch and KO-7246 Preclinical Data in Diabetes
2026-10-07 11:15 · Yahoo
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-10-02 11:30 · Yahoo
Caspian Therapeutics Appoints Manasi Jaiman, M.D., M.P.H., and Elizabeth Mily to Board of Directors
2026-10-01 11:02 · Yahoo
Caspian Therapeutics Unveils KO-7246 at EASD as a Potential Best-In-Class Menin Inhibitor for Diabetes
2026-09-29 09:15 · Yahoo
Kura spins diabetes work into a Lilly-backed biotech startup
2026-09-09 15:54 · Yahoo
Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes
2026-09-09 11:00 · Yahoo
Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer
2026-09-08 11:00 · Yahoo
Kura Oncology (KURA) Stock Looks Fully Priced After Its 56% Run
2026-09-02 23:06 · Yahoo
Kura Oncology to Participate in Three Investor Conferences in September
2026-09-01 11:15 · Yahoo
Kura Oncology (KURA) Upgraded to Buy: What Does It Mean for the Stock?
2026-08-31 16:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.